J

Juan Manuel Sánchez‐Hidalgo

Instituto Maimónides de Investigación Biomédica de Córdoba

11 papers and 76 citations.

11Publications

76Total Citations

Top publicationsby citations

Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drug

Emilia Alors‐Pérez, Justo P. Castaño, Álvaro Arjona‐Sánchez et al.|Journal of Experimental & Clinical Cancer Research|2021

Cited by 60

Spliceosomic dysregulation in pancreatic cancer uncovers splicing factors <scp>PRPF8</scp> and <scp>RBMX</scp> as novel candidate actionable targets

Emilia Alors‐Pérez, Justo P. Castaño, Ricardo Blázquez‐Encinas et al.|Molecular Oncology|2024

Cited by 8

External multicentre validation of pseudomyxoma peritonei PSOGI-Ki67 classification

Álvaro Arjona‐Sánchez, Wouter Willaert, Ana Martínez-López et al.|European Journal of Surgical Oncology|2023

Cited by 6

Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drug

Emilia Alors‐Pérez, Justo P. Castaño, Ricardo Blázquez‐Encinas et al.|Research Square|2021

Cited by 2

The expression profile of telomerase complex components reveals novel prognostic insights in pancreatic ductal adenocarcinoma

Cristina Viyuela-García, Justo P. Castaño, Juan Manuel Sánchez‐Hidalgo et al.|Pancreatology|2021

Cited by 0

Indexing the rest of 11 publications…